Syrris Establishes Brazilian Subsidiary
News Feb 01, 2010
With offices on four continents and an expanding distributor network, the new office in São Paulo will enable Syrris to provide efficient and direct support to its rapidly expanding Latin American customer base.
Syrris designs and manufactures world-leading flow chemistry, microreactor and automation products for research and development chemists. The company’s flow chemistry products include the FRX, a modular flow chemistry system, and Africa, a fully-automated microreactor flow system. Syrris’s batch reactor products include Atlas, a manual or automated system for control of one or parallel reactions of up to 5 litres in vials, flasks or jacketed reactors. Within this innovative Atlas range is the Atlas Calorimeter, a high performance reaction calorimeter for heat flow and power compensation calorimetry.
“With a significant increase in customer sales in 2009, this is an extremely exciting way for us to begin the New Year”, commented Mike Hawes, Chief Executive Officer. He continued, “Establishing a subsidiary office in Brazil not only reflects the increasing interest in our product range worldwide, but more specifically the increased requirement for our complete product range within the Brazilian and Latin American research and development chemistry industry.”
New Chemical Synthesis Process: Synergy of Two Catalysts in One FlaskNews
Researchers report the one-step synthesis of a ketone from an aldehyde by the combination of thiazolium N-heterocyclic carbene and palladium/bisphosphine catalysts in one flask. The two catalysts function in a synergistic manner. This study is expected to lead to new synthesis processes of precursor compounds for medications.READ MORE
Synthesis of Drug-Like Molecules Simplified Using New Cross-Coupling MethodNews
Researchers have designed a new molecule-building method. The technique, described recently in the journal Science, paves the way toward other new chemical reactions and facilitates the synthesis of pharmaceutically-relevant molecules.READ MORE
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
10th International Conference on Mass Spectrometry and Chromatography
Oct 08 - Oct 09, 2018